Each month the Levy Library showcases the achievements of Mount Sinai faculty and researchers by highlighting an article and its altmetrics. Altmetrics are alternative measures of impact that capture non-traditional data like abstract views, article downloads, and social media activity.
This month we highlight Comprehensive Characterization of Cancer Driver Genes and Mutations, written by a team of researchers including Mount Sinai’s John Martignetti (Genetics and Genomics), Robert Krost (Thoracic Surgery), and Peter Dottino (Obstetrics, Gynecology and Reproductive Services).
Citation: Cell, 2018 Apr 5;173(2):371-385.e18. doi: 10.1016/j.cell.2018.02.060. Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, Colaprico A, Wendl MC, Kim J, Reardon B, Ng PK, Jeong KJ, Cao S, Wang Z, Gao J, Gao Q, Wang F, Liu EM, Mularoni L, Rubio-Perez C, Nagarajan N, Cortés-Ciriano I, Zhou DC, Liang WW, Hess JM, Yellapantula VD, Tamborero D, Gonzalez-Perez A, Suphavilai C, Ko JY, Khurana E, Park PJ, Van Allen EM, Liang H; MC3 Working Group; Cancer Genome Atlas Research Network, Lawrence MS, Godzik A, Lopez-Bigas N, Stuart J, Wheeler D, Getz G, Chen K, Lazar AJ, Mills GB, Karchin R, Ding L.
Abstract
Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced algorithms to identify drivers now exist, but systematic attempts to combine and optimize them on large datasets are few. We report a PanCancer and PanSoftware analysis spanning 9,423 tumor exomes (comprising all 33 of The Cancer Genome Atlas projects) and using 26 computational tools to catalog driver genes and mutations. We identify 299 driver genes with implications regarding their anatomical sites and cancer/cell types. Sequence- and structure-based analyses identified >3,400 putative missense driver mutations supported by multiple lines of evidence. Experimental validation confirmed 60%-85% of predicted mutations as likely drivers. We found that >300 MSI tumors are associated with high PD-1/PD-L1, and 57% of tumors analyzed harbor putative clinically actionable events. Our study represents the most comprehensive discovery of cancer genes and mutations to date and will serve as a blueprint for future biological and clinical endeavors.
See Dr. John Martignetti on PLUMX
See Robert Krost on PLUMX
See Dr. Petter Dottino on PLUMX
Levy Library is happy to announce a new resource available to the Mount Sinai Health System community: PubsHub, the place to find key scientific venues to publish your data.
PubsHub is a database of submission criteria for peer-reviewed medical journals and congresses. Easily compare critical venue metrics across 100+ therapeutic areas to determine what is best suited for your needs. It covers more than 3,500 journals, with indispensable data such as journal impact factors, acceptance rates and publication turnaround times.
You can access PubsHub directly through their website or through our database list.